Intas Pharmaceuticals has announced the appointment of Rajasekhar Akkaraju (Raj) as its Chief Quality Officer, reinforcing the company’s commitment to global quality excellence and regulatory compliance. With extensive experience across pharmaceuticals, biosimilars, and active pharmaceutical ingredients (API), Rajasekhar brings deep expertise in building and strengthening enterprise-wide quality frameworks.
By Super Admin
|
April
14, 2026
